Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03815058 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma. (IMCODE001) |
| First Submitted : | January 7, 2019 |
| First Submitted that Met QC Criteria : | January 23, 2019 |
| First Posted : | January 24, 2019 |
| Last Update Submitted that Met QC Criteria : | April 25, 2024 |
| Last Update Posted : | April 26, 2024 |